Matching-adjusted indirect treatment comparison of [(177)Lu]Lu-DOTA-TATE, everolimus and sunitinib in advanced, unresectable gastroenteropancreatic neuroendocrine tumours: Relative effectiveness of [(177)Lu]Lu-DOTA-TATE in gastroenteropancreatic neuroendocrine tumours

Head-to-head comparisons of the efficacy of treatments for gastroenteropancreatic neuroendocrine tumours (GEP-NETs) have not yet been reported. This study used a series of matching-adjusted indirect comparisons to indirectly compare the effectiveness of [(177)Lu]Lu-DOTA-TATE to everolimus, sunitinib...

Descripción completa

Detalles Bibliográficos
Autores principales: Khan, Mohid S., Stamp, Elaine, Sammon, Cormac, Brabander, Tessa, de Herder, Wouter W., Pavel, Marianne E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8591206/
https://www.ncbi.nlm.nih.gov/pubmed/34912478
http://dx.doi.org/10.1016/j.ejcsup.2021.06.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8591206/
https://www.ncbi.nlm.nih.gov/pubmed/34912478
http://dx.doi.org/10.1016/j.ejcsup.2021.06.002

Ejemplares similares